ReviewMedical oncology (Northwood, London, England)2018

Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents.

Roberto Castelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.